EUVIMEDEUVIMED entdecken
Crossref

Nosologic Reappraisal of the Recently Proposed Calcified Chondroid Mesenchymal Neoplasm Concept in a Series of 20 Cases

Shogo Nishino, Taisuke Mori, Hajime Umezu, Kohtaro Eguchi, Toshihide Hirai, Ryouji Yamada, Shinsuke Ohshima, Yasushi Yatabe, Seiichi Yoshimoto, Akira Kawai, Toru Motoi, Akihiko Yoshida

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Shogo Nishino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan; Course of Advanced Clinical Research of Cancer, Juntendo Universit…. Hauptthemen laut MEDLINE: Calcinosis, Biomarkers, Tumor, Bone Neoplasms, Soft Tissue Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

"Calcified chondroid mesenchymal neoplasm (CCMN)" is a recently proposed term for tumors with hypercellular chondroid histology and fusion genes. However, its impact on the present classification framework has not been extensively investigated. In this study, we analyzed 20 tumors with histology that would fit with that reported as "CCMN." With the combined use of RNA sequencing and fluorescence in situ hybridization, 15 tumors were found to have gene fusions, including FN1::FGFR2 (n = 4), FN1::TEK (n = 1), FN1::MERTK (n = 1), PDGFRA::USP8 (n = 2), FN1 rearrangements with undetermined non-FGFR2 partners (n = 4), and PDGFRA rearrangements with undetermined partners (n = 3). FN1 or PDGFRA rearrangement signals were restricted to epithelioid/polygonal cells, indicating that these were neoplastic elements mixed with abundant reactive cells. The fusion-positive tumors were found in 7 men and 8 women aged 29 to 82 years (median, 57 years), and most involved the temporomandibular joints or digits. Tumors showed a chondroid matrix with grungy calcification and cellular components with epithelioid/polygonal cells and were divided into 2 groups the histology of which corresponded to chondroid tenosynovial giant cell tumor or soft-tissue chondroma. Three fusion-positive tumors harbored calcium pyrophosphate dihydrate crystals. Nuclear atypia was frequent. Gene fusions were not detected in the remaining 5 tumors with abundant crystal/calcium deposition, and some may represent reactive conditions. All 20 tumors followed an indolent clinical course, and 4 patients with temporomandibular joint tumors were successfully followed up without surgery for 9 to 60 months. Using "CCMN" as an entity would entail mixed repercussions in diagnostic practice, and how and whether it should be used in diagnosis requires deliberate discussion. The concept may bring some benefits, but it may arguably cause more confusion because it would substantially restructure the conventional framework by drawing a boundary within the chondroma and conflating the chondroma with chondroid tenosynovial giant cell tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalcinosisBiomarkers, TumorBone NeoplasmsSoft Tissue NeoplasmsMesenchymomaHumansFemaleMaleMiddle AgedAdultAgedIn Situ Hybridization, FluorescenceGene FusionYoung AdultAged, 80 and overChondroma

Stichwörter der Autor:innen

FN1PDGFRAcalcified chondroid mesenchymal neoplasmchondromatenosynovial giant cell tumortophaceous pseudogout

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Division of Pathology, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Department of Head and Neck Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Department of Neurosurgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nishino, S., Mori, T., Umezu, H., Eguchi, K., Hirai, T., Yamada, R., Ohshima, S., Yatabe, Y., Yoshimoto, S., Kawai, A., Motoi, T., & Yoshida, A. (2025). Nosologic Reappraisal of the Recently Proposed Calcified Chondroid Mesenchymal Neoplasm Concept in a Series of 20 Cases. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100762

Vancouver

Nishino S, Mori T, Umezu H, Eguchi K, Hirai T, Yamada R, et al. Nosologic Reappraisal of the Recently Proposed Calcified Chondroid Mesenchymal Neoplasm Concept in a Series of 20 Cases. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100762

BibTeX
@article{Nishino2025,
  author = {Nishino, Shogo and Mori, Taisuke and Umezu, Hajime and Eguchi, Kohtaro and Hirai, Toshihide and Yamada, Ryouji and Ohshima, Shinsuke and Yatabe, Yasushi and Yoshimoto, Seiichi and Kawai, Akira and Motoi, Toru and Yoshida, Akihiko},
  title = {Nosologic Reappraisal of the Recently Proposed Calcified Chondroid Mesenchymal Neoplasm Concept in a Series of 20 Cases},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100762}
}
Kostenlos starten →